Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. Article

authors

  • Morgan, RA
  • Chinnasamy, N
  • Abate-Daga, D
  • Gros, A
  • Robbins, PF
  • Zheng, Z
  • Dudley, ME
  • Alimchandani, M
  • Feldman, SA
  • Yang, JC
  • Sherry, RM
  • Phan, GQ
  • Hughes, Marybeth S.
  • Kammula, US
  • Miller, AD
  • Hessman, CJ
  • Stewart, AA
  • Restifo, NP
  • Quezado, MM
  • Rosenberg, AZ
  • Nath, A
  • Wang, T
  • Bielekova, B
  • Wuest, SC
  • Akula, N
  • McMahon, FJ
  • Wilde, S
  • Mosetter, B
  • Schendel, DJ
  • Laurencot, CM
  • Rosenberg, SA

publication date

  • 2013

published in

PubMed Central ID

  • pmc3581823

start page

  • 133

end page

  • 51

volume

  • 36

issue

  • 2